When I speak to patients in the pharmacy about their bioidentical hormone replacement therapy (BHRT) product, I like to make a differentiation between “tangible” benefits and “intangible” benefits to help explain the effects of their medication. I define tangible benefits as direct improvements in the...
Our enhanced ProPell platform is currently under development and scheduled to launch in January 2027.
In the meantime, providers can still access ProPell education, dosing resources, marketing materials, and implementation support through our current program.
Our team remains available to help providers successfully
implement and grow their pellet therapy programs.
